February 16, 2017- New York State (NYS) has seen an increase in the number of HCV cases reported among women of child bearing age (15-44 years). During 2015, 58% of the female HCV cases reported outside of NYC (ROS) were among women of child bearing age. This is an increase from 36% in 2005. Among females of childbearing age, with known IDU status, 87% reported a history of IDU. In 2015, 33% of all female HCV cases reported in NYC were among women of child bearing age.
As a result of this increase, we have issued a Dear Colleague letter to inform the provider community about the importance of hepatitis C screening and linkage to care for women of child bearing age with an identified HCV risk, such as injection drug use. Women who are screened and diagnosed with HCV should be referred for HCV treatment with one of the highly effective direct acting antivirals, to eliminate the risk of vertical transmission.
Dear Colleague Letter
Link to webinar recording
Hepatitis C Education Materials order form
Hepatitis C: Screening, Diagnosis and Linkage to Care Booklet